S. Mirski

发表

Nuclear interactions of topoisomerase II α and β with phospholipid scramblase 1

J. Wyles, Zhongqin Wu, S. Mirski, 2007, Nucleic acids research.

Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II.

S. Mirski, S. Cole, F. Dicke, 1991, Cancer research.

Reduced levels of topoisomerase IIα and IIβ in a multidrug-resistant lung-cancer cell line

M. Danks, S. Mirski, S. Cole, 2004, Cancer Chemotherapy and Pharmacology.

Simultaneous Quantitation of Topoisomerase II α and β Isoform mRNAs in Lung Tumor Cells and Normal and Malignant Lung Tissue

T. Voskoglou-Nomikos, S. Mirski, S. Cole, 2000, Laboratory Investigation.

Altered topoisomerase II alpha in a drug-resistant small cell lung cancer cell line selected in VP-16.

M. Slovak, S. Mirski, S. Cole, 1993, Cancer research.

Antigens associated with multidrug resistance in H69AR, a small cell lung cancer cell line.

S. Mirski, S. Cole, 1989, Cancer research.

Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization.

M. Sehested, J. Falck, S. Mirski, 1997, Cancer research.

Cytoplasmic localization of a mutant M(r) 160,000 topoisomerase II alpha is associated with the loss of putative bipartite nuclear localization signals in a drug-resistant human lung cancer cell line.

S. Mirski, S. Cole, 1995, Cancer research.

Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.

S. Mirski, S. Cole, H. Downes, 1990, Molecular pharmacology.

Bipartite nuclear localization signals in the C terminus of human topoisomerase II alpha.

R. Zirngibl, P. Greer, S. Mirski, 1997, Experimental cell research.

Tumourigenic multidrug-resistant HT1080 cells do not overexpress receptors for epidermal growth factor.

J. Trent, M. Slovak, S. Mirski, 1991, British Journal of Cancer.

Subcellular localization analysis of the closely related Fps/Fes and Fer protein-tyrosine kinases suggests a distinct role for Fps/Fes in vesicular trafficking.

R. Zirngibl, P. Greer, S. Mirski, 2001, Experimental cell research.

with the Loss of Putative Bipartite Nuclear Localization Signals in a Drug-resistant Human Lung Cancer Cell Line1

S. Mirski, S. Cole, 1995 .

Differential expression of the Leu-7 antigen on human lung tumor cells.

J. Roder, R. Mcgarry, S. Mirski, 1985, Cancer research.

A monoclonal antibody detecting cell surface epitope on some drug resistant human tumour cell lines.

S. Mirski, S. Cole, S. A. Mohamdee, 1990, British Journal of Cancer.

Multidrug resistance-associated antigens on drug-sensitive and -resistant human tumour cell lines.

S. Mirski, S. Cole, 1991, British Journal of Cancer.

Levels of Topoisomerase II Susceptibility to Drug-induced DNA Damage and Reduced Cell Lung Cancer Cell Line : Evidence for Decreased Non-P-glycoprotein-mediated Multidrug Resistance in a Small Updated

S. Mirski, S. Cole, F. Dicke, 2006 .

Cellular and karyotypic characterization of two doxorubicin resistant cell lines isolated from the same parental human leukemia cell line

L. Campbell, J. Zalcberg, P. Kantharidis, 1994, International journal of cancer.

THE MUCOSAL IMMUNOLOGICAL NETWORK: COMPARTMENTALIZATION OF LYMPHOCYTES, NATURAL KILLER CELLS, AND MAST CELLS *

J. Bienenstock, S. Mirski, A. Tagliabue, 1983, Annals of the New York Academy of Sciences.

Regulation of lymphoblast traffic and localization in mucosal tissues, with emphasis on IgA.

J. Bienenstock, K. Rosenthal, S. Mirski, 1983, Federation proceedings.

HT1080cells donotoverexpress receptors forepidermal growth factor

J. Trent, M. Slovak, S. Mirski, 1991 .

Growth of human x human hybridomas in protein-free medium supplemented with ethanolamine.

S. Mirski, S. Cole, B. Campling, 1987, Journal of immunological methods.

Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.

S. Mirski, S. Cole, J. Gerlach, 1987, Cancer research.

Identification of functional nuclear export sequences in human topoisomerase IIα and β

S. Mirski, S. Cole, J. Bielawski, 2003 .

Altered subcellular distribution of topoisomerase II alpha in a drug-resistant human small cell lung cancer cell line.

D. Sullivan, S. Mirski, S. Cole, 1994, Cancer research.

Sequence determinants of nuclear localization in the alpha and beta isoforms of human topoisomerase II.

S. Mirski, S. Cole, S P Cole, 1999, Experimental cell research.

Structural organization of the human TOP2A and TOP2B genes.

S. Mirski, S. Cole, J. Gerlach, 1998, Gene.

Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.

C. Lok, S. Mirski, S. Cole, 2002, The Biochemical journal.

Title Characterization of the human topoisomerase II β ( TOP 2 B ) promoter activity : Essential roles of the nuclear factorY ( NF-Y )-and specificity protein-1 ( Sp 1 )-binding sites

S. Mirski, S. Cole, A. J. Lang, 2022 .

Identification of functional nuclear export sequences in human topoisomerase IIalpha and beta.

S. Mirski, S. Cole, J. Bielawski, 2003, Biochemical and biophysical research communications.

Topoisomerase II binds importin alpha isoforms and exportin/CRM1 but does not shuttle between the nucleus and cytoplasm in proliferating cells.

Y. Mo, W. T. Beck, S. Mirski, 2007, Experimental cell research.

Two COOH-terminal truncated cytoplasmic forms of topoisomerase II alpha in a VP-16-selected lung cancer cell line result from partial gene deletion and alternative splicing.

S. Mirski, S. Cole, K. E. Sparks, 1997, Biochemistry.

Line Selected in Adriamycin Multidrug Resistance in a Human Small Cell Lung Cancer Cell Updated Version Citing Articles E-mail Alerts Multidrug Resistance in a Human Small Cell Lung Cancer Cell Line Selected in Adriamycin1

S. Mirski, S. Cole, J. Gerlach, 2022 .